Adequan® i.m. (Polysulfated Glycosaminoglycan – PSGAG)
Injectable Solution for Intramuscular Use in Horses
Product Overview
Buy Adequan i.m online, is an FDA-approved injectable medication designed to treat joint dysfunction caused by non-infectious degenerative joint disease (DJD) in horses. It aids in managing lameness and discomfort by promoting cartilage repair and reducing inflammation within the joints.
Key Benefits of Buy Adequan i.m online
- Supports Joint Health: Stimulates cartilage repair and protects existing cartilage from degradation.
- Reduces Inflammation: Inhibits enzymes that cause joint inflammation and breakdown of cartilage.
- Pain Relief: Addresses the underlying causes of joint pain, providing sustained relief.
- Improves Mobility: Helps horses regain comfort and range of motion for better performance.
Indications
Adequan® i.m. is indicated for:
- Non-infectious degenerative joint disease (DJD).
- Supportive treatment in managing joint injuries.
- Maintenance of joint health in performance and working horses.
Dosage and Administration
- Route: Intramuscular injection.
- Standard Dosage: 500 mg (5 mL) intramuscularly every 4 days for a total of 7 treatments (28 days).
- Administration: Ensure aseptic techniques and consult a veterinarian for proper dosing and scheduling.
Mechanism of Action
Polysulfated glycosaminoglycan (PSGAG) mimics the natural components of joint cartilage. It works by:
- Stimulating the production of healthy cartilage matrix.
- Inhibiting enzymes that break down cartilage and synovial fluid.
- Enhancing the viscosity of synovial fluid to improve joint lubrication.
Safety and Precautions
- For Horses Only: Not for use in humans or other animal species.
- Contraindications:
- Do not use in horses with known hypersensitivity to PSGAG.
- Avoid use in horses with bleeding disorders.
- Adverse Reactions: Rarely, mild local swelling or sensitivity may occur at the injection site.
Warnings
- Pregnancy and Lactation: Safety in pregnant mares has not been established. Consult a veterinarian before use.
- Drug Interactions: Use with caution when combined with anticoagulant drugs, as PSGAG has mild anticoagulant effects.
- Withdrawal Period: Not established. Avoid use in horses intended for human consumption.
Storage
- Store at controlled room temperature (68°F–77°F or 20°C–25°C).
- Protect from light and freezing.
Why Choose Adequan® i.m.?
Adequan® i.m. is trusted by veterinarians and horse owners for its proven efficacy in treating DJD. By addressing the root causes of joint deterioration, it ensures long-lasting joint health and helps horses return to peak performance.
Always consult your veterinarian before starting treatment with Adequan® i.m. to ensure it is appropriate for your horse’s condition.
Reviews
There are no reviews yet.